|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, June 16, 2016 ) Executive Summary
Rheumatoid arthritis (RA) is a chronic inflammatory disorder that principally attacks synovial joints. It is one of the most common autoimmune diseases affecting people of all ages and races. RA affects the lining of joints, causing a painful swelling that can eventually result in bone erosion and joint deformity. It also leads to stiffness, and redness in the joints. The main factor causing Rheumatoid arthritis remains unknown. However, according to studies around the world some of the genetic and environmental factors are found to be more probable causers.
Treatment of Rheumatoid Arthritis involves frequent drugs administration as RA is a progressive and incurable disease. Drugs used for treatment of RA are classified as first line agents- consisting of non steroidal anti-inflammatory drugs (NSAIDs) and steroids such as glucocorticoids and second line agents- consisting of disease modifying anti-rheumatic drugs such as chloroquine, gold salts, penicillamine, cyclosporine, and several biological agents like TNF-
Download free Sample PDF report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=186839
Scope of the report
The report titled Global Rheumatoid Arthritis Market: Trends and Opportunities (2013-2018) provides an in-depth analysis of global rheumatoid arthritis market with special focus on biologics drugs. It also accesses the key opportunities and underlying trends in the market and outlines the factors that are and will be driving the growth of the industry in the forecasted period (2013-18). Further, key drug manufacturers of the global rheumatoid arthritis market like Abbvie Inc. (Humira), Amgen Inc. (Enbrel), Johnson & Johnson (Remicade), Roche Holdings AG (Actemra) are profiled in the report.
Company Coverage
Abbvie Inc.
Amgen Inc.
Johnson & Johnson
Roche Holdings AG
Read All Biotechnology Market Research Reports @ http://www.researchmoz.us/biotechnology-market-reports-30.html
Table of Content
1. Executive Summary
2. Rheumatoid Arthritis: An Introduction
2.1 Rheumatoid Arthritis: Causes
2.2 Rheumatoid Arthritis: Symptoms & Diagnosis
2.2.1 Rheumatoid Arthritis: Symptoms
2.2.2 Rheumatoid Arthritis: Diagnosis
3. Rheumatoid Arthritis Treatment
3.1 Clinical Evolution of Rheumatoid Arthritis Treatment
3.2 Rheumatoid Arthritis: Drugs Treatment
3.2.1 First line agents
3.2.2 Second line agents
4. Global Rheumatoid Arthritis Market Analysis
4.1 Global Rheumatoid Arthritis Treatment Market: Size & Growth (Actual & Forecast)
4.2 Global Rheumatoid Arthritis Treatment Market Analysis
4.2.1 Global Biologics Drugs Market Size (Actual & Forecast)
4.2.2 Global Rheumatoid Arthritis Biologics Drugs Market Share (Actual & Forecast)
4.2.3 Global TNF-α target Antibody Market Size (Actual & Forecast)
Contact Us:
Mr. Nachiket
Albany NY - 12207
United States
Tel: +1-518-621-2074
Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
About ResearchMoz
ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Researchmoz Global Pvt.Ltd
Researchmoz
+1-518-621-2074
sales@researchmoz.us
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
